Pura Vida Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALMR
Alamar Biosciences
ALMR
|
+$17.1M |
| 2 |
Coca-Cola
KO
|
+$197K |
| 3 |
Microsoft
MSFT
|
+$4.05K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.57K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMDX
Insight Molecular Diagnostics
IMDX
|
+$2.28M |
| 2 |
CAI
Caris Life Sciences
CAI
|
+$1.15M |
| 3 |
Natera
NTRA
|
+$213K |
| 4 |
NVIDIA
NVDA
|
+$41.1K |
| 5 |
BBNX
Beta Bionics
BBNX
|
+$1.02K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.44% |
| 2 | Technology | 5.26% |
| 3 | Financials | 1.19% |
| 4 | Communication Services | 1.15% |
| 5 | Consumer Discretionary | 0.71% |
No holdings matched the selected filter criteria.
Similar funds
Pura Vida Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Pura Vida Investments held 19 positions worth $37M, up 149% from $14.9M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Pura Vida Investments deployed $13.6M of net new capital in Q2 2026, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Alamar Biosciences: 755,909 shares worth $20.5M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 81% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Insight Molecular Diagnostics, an estimated $2.28M trimmed.
- Pura Vida Investments's largest Q2 2026 buy was Alamar Biosciences: 755,909 shares worth $20.5M.
- Pura Vida Investments added most to Microsoft in Q2 2026, an estimated $4.05K increase.
- Pura Vida Investments's biggest Q2 2026 reduction was Insight Molecular Diagnostics, cutting an estimated $2.28M.
- Pura Vida Investments's ten largest holdings make up 92% of its $37M portfolio in Q2 2026.
- Pura Vida Investments opened 2 new positions and closed 0 in Q2 2026.
- Pura Vida Investments's portfolio value rose 149% quarter-over-quarter to $37M.
Based on Pura Vida Investments's 13F filing for Q2 2026, filed 13 Aug 2026.